QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 citigroup-upgrades-nevro-to-neutral-announces-689-price-target

Citigroup analyst Joanne Wuensch upgrades Nevro (NYSE:NVRO) from Sell to Neutral and announces $6.89 price target.

 wolfe-research-upgrades-nevro-to-peer-perform

Wolfe Research analyst Mike Polark upgrades Nevro (NYSE:NVRO) from Underperform to Peer Perform.

 truist-securities-maintains-hold-on-nevro-lowers-price-target-to-55

Truist Securities analyst Richard Newitter maintains Nevro (NYSE:NVRO) with a Hold and lowers the price target from $10 to $...

 jmp-securities-downgrades-nevro-to-market-perform

JMP Securities analyst David Turkaly downgrades Nevro (NYSE:NVRO) from Market Outperform to Market Perform.

 rbc-capital-maintains-sector-perform-on-nevro-lowers-price-target-to-7

RBC Capital analyst Shagun Singh maintains Nevro (NYSE:NVRO) with a Sector Perform and lowers the price target from $16 to $7.

 baird-maintains-neutral-on-nevro-lowers-price-target-to-8

Baird analyst Mike Polark maintains Nevro (NYSE:NVRO) with a Neutral and lowers the price target from $11 to $8.

 wells-fargo-downgrades-nevro-to-underweight-lowers-price-target-to-55

Wells Fargo analyst Nathan Treybeck downgrades Nevro (NYSE:NVRO) from Equal-Weight to Underweight and lowers the price targe...

 jp-morgan-downgrades-nevro-to-underweight

JP Morgan analyst Robbie Marcus downgrades Nevro (NYSE:NVRO) from Neutral to Underweight.

 piper-sandler-maintains-underweight-on-nevro-lowers-price-target-to-7

Piper Sandler analyst Adam Maeder maintains Nevro (NYSE:NVRO) with a Underweight and lowers the price target from $12 to $7.

 nevro-q2-2024-gaap-eps-053-beats-068-estimate-sales-104161m-miss-107347m-estimate

Nevro (NYSE:NVRO) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.68) by 22.06 ...

 truist-securities-maintains-hold-on-nevro-lowers-price-target-to-10

Truist Securities analyst Richard Newitter maintains Nevro (NYSE:NVRO) with a Hold and lowers the price target from $11 to $10.

 morgan-stanley-maintains-equal-weight-on-nevro-lowers-price-target-to-9

Morgan Stanley analyst Cecilia Furlong maintains Nevro (NYSE:NVRO) with a Equal-Weight and lowers the price target from $14 ...

 citigroup-maintains-sell-on-nevro-lowers-price-target-to-82

Citigroup analyst Joanne Wuensch maintains Nevro (NYSE:NVRO) with a Sell and lowers the price target from $9 to $8.2.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION